BTA-TRAK(TM) - A useful diagnostic tool in urinary bladder cancer?

Anticancer Research

Volumn 19, Issue 4 A, 1999, Pages 2615-2619

  Mahnert, Brigitte ^a   Tauber, Stephan ^b   Kriegmair, M ^b   Schmitt, Ursula Maria ^a   Hasholzner, Ute ^a   Reiter, W ^a   Hofmann, Karin ^a   Schmeller, N ^b   Stieber, Petra ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

BTA TRAK(TM); Diagnosis; Urinary bladder cancer

Indexed keywords

BLADDER CANCER; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; HEMATURIA; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; URINALYSIS; URINARY TRACT DISEASE; URINE LEVEL; ANALYTICAL EQUIPMENT; ARTICLE; BLADDER TUMOR; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; ENZYME IMMUNOASSAY; PATHOLOGY; RECURRENT DISEASE; REFERENCE VALUE; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINARY TRACT INFECTION; URINE;

CYSTOSCOPY; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOENZYME TECHNIQUES; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; RECURRENCE; REFERENCE VALUES; ROC CURVE; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; URINARY TRACT INFECTIONS; UROLOGIC DISEASES;

EID: 0032586757     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Catalona WJ: Bladder cancer. In: Adult and Pediatric Urology, 2nd ed. Edited by Gillenwater JY, Graychuck YT, Howards SS and Duckett JW, St. Louis: Mosby Year Book, vol 1, chapt 31, pp. 1135-1184, 1991.
2. Loening S, Narayana A, Yoder L, Slymen D, Weinstein S, Penick G and Culp D: Factors influencing the recurrence rate of bladder cancer. J Urol 123: 29, 1980.
3. Ianari A, Sternberg CN, Rossetti A, Van Rijn A, Deidda A, Giannerelli D and Pansadoro V: Results of Bard BTA test in monitoring patients with a history of transitional cell cancer of the bladder. Urology 49: 786, 1997.
4. Sarosdy MF, de Vere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer P F, Jarowenko MJ, Adams G and Blumenstein BA: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer. J Urol 154: 379, 1995.
5. Leyh H, Mazeman E, Hall RR, Bennett A: Results of a European multicentre trial comparing the BARD BTA test to urine cytology in patients suspected of having bladder cancer. Proceedings of the American Urological assiciation 1996, Abstract no 726.
6. The United Kingdom and Eire Bladder Tumor Antigen Study Group: The use of the bladder-tumour associated analyte test to determine the type of cystoscopy in the follow-up of patients with bladder cancer: Brit J Urol 79: 362, 1997.
7. van Dalen A: Qualitiy control and standardization of tumour marker tests. Tumor Biol 14: 131-135, 1993.
8. Johnston B, Morales A, Emerson L and Lundie M: Rapid Detection of Bladder Cancer: A Comparative Study of Point of Care Tests: J Urol 158: 2098-2101, 1997.
9. William M Murphy, Inoel Rivera-Ramirez, Camilo A Medina, Nancy J Wright and Zev Wajsman: The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms. J Urol 158: 2102, December 1997.
10. Layfield L: Department of Urology, Duke University medical Center, Durham, North Carolina, Editional Comment to Sarosdy MF et al: Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer, J Urol 154: 379-384, 1995.